TETRAPHASE PHARMACEUTICALS I
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TETRAPHASE PHARMACEUTICALS I PUT, CUSIP 88165N955.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for TETRAPHASE PHARMACEUTICALS I PUT, CUSIP 88165N955.